Agreement - March 14, 2017
Bonesupport extends US distribution agreement
BONESUPPORT has extended the term of its U.S. distribution agreement with Zimmer Biomet, where Zimmer will continue to have exclusive rights for BONESUPPORT’s cerament bone void filler product line for Orthopedics, Trauma and Foot and Ankle indications in the United States. “We are extremely pleased to extend our distribution agreement with Zimmer Biomet,” said Richard […]
In a new job - January 5, 2017
Björn Westberg to join BONESUPPORT as CFO
BONESUPPORT announces that Björn Westberg is to join the company as Chief Financial Officer and Director in early 2017. Mr Westberg brings nearly 30 years’ finance and management experience to BONESUPPORT. He joins from Recipharm where he has been CFO since 2007. Prior to this he was CFO of the listed (Nasdaq Stockholm) software company Jeeves […]
In a new job - November 7, 2016
Bonesupport announces key appointment
Swedish BONESUPPORT has announced the appointment of Patrick O’Donnell as General Manager and Executive Vice President, North American Commercialization. O’Donnell will lead the relationship with the company’s partner, Zimmer Biomet, to drive revenue growth of BONESUPPORT’s CERAMENT BONE VOID FILLER (BVF). He will also set the strategy for the introduction of CERAMENT G, a novel […]
Financing - October 28, 2016
Bonesupport raises $37 million
BONESUPPORT has raised $37 million (SEK 327 million) in a combination of equity and debt finance and the new funds will be used to deliver further value from its unique CERAMENT platform. The oversubscribed equity financing was led by Tellacq AB and was supported by the Company’s current major shareholders, including HealthCap, Lundbeckfond Ventures, Industrifonden, […]
Clinical Trials Medtech - September 8, 2016
Bonesupport presents positive results
Bonesupport, a company focusing on innovative injectable bioresorbable bone graft substitute products to treat bone voids caused by trauma, infection, disease or related surgery, has announced the publication of a paper in The Bone and Joint Journal. The paper (Single-stage treatment of chronic osteomyelitis with a new absorbable gentamicin-loaded, calcium sulphate/hydroxyapatite biocomposite – A prospective series […]
